Effect of isolated ultrafiltration on plasma hormone levels in patients with heart failure resistant to drug therapy
Zaruba, A.I.; Kutsenko, A.I.; Kukharchuk, V.V.; Masenko, V.P.
Kardiologiia 29(9): 46-49
1989
ISSN/ISBN: 0022-9040 PMID: 2687556 Document Number: 342004
The positive action exerted by isolated ultrafiltration on 69 patients with refractory heart failure was shown to be due to the complex interaction of effects produced by ultrafiltrate removal. Among the effects, a leading role is played by therapy for hyperaldosteronism and reduction of antidiuretic hormone levels along with improvement of the functional status of the liver and heart.
Document emailed within 1 workday
Related Documents
Gadzhiev, N.G.; Gadzhiev, G.G.; Samedov, R.I. 1992: Experience in the treatment of patients with severe heart failure using isolated ultrafiltration Kardiologiia 32(9-10): 111-112Ragazzoni, E.; Sacco, A.; Cusinato, S.; Agliata, S.; Schweiger, K.; Cavagnino, A.; Zanetta, M.; Cardillo, V.; Corrà, U. 1998: Heart failure resistant to drug therapy. Nephrologic approach Minerva Urologica e Nefrologica 50(2): 133-138
Fujita, S.; Chiba, M.; Ohta, M.; Kitani, K.; Suzuki, T. 1990: Alteration of plasma sex hormone levels associated with old age and its effect on hepatic drug metabolism in rats Journal of Pharmacology and Experimental Therapeutics 253(1): 369-374
Zaccara, G.; Galli, A.; Rossi, L.; Zappoli, R.; Zatelli, L.; Amaducci, L. 1977: Plasma levels of diphenylhydantoin (DPH) and phenobarbitone (PB) in epileptic patients resistant to drug treatment Rivista di Patologia Nervosa E Mentale 98(6): 363-375
Zur Mühlen A von; Hesch, R.D.; Emrich, D.; Creutzfeldt, W. 1970: Effect of synthetic "thyreotropin releasing factor" on the plasma levels of thyreotropic hormone and growth hormone in healthy subjects, in patients with hyperthyreosis and primary hypothyreosis Deutsche Medizinische Wochenschrift 95(52): 2623-2624
Funaya, H.; Kitakaze, M.; Node, K.; Minamino, T.; Komamura, K.; Hori, M. 1997: Plasma adenosine levels increase in patients with chronic heart failure Circulation 95(6): 1363-1365
Tovena, D.M.; Pedrinazzi, C.; Ogliari, V.; De Petri, G.; Mileti, M.; Inama, G. 2008: Non-pharmacological therapy of decompensated heart failure: the extracorporeal ultrafiltration Giornale Italiano di Cardiologia 9(10 Suppl 1: 118s-122s
Hou, F.; Zhu, S.; Li, L.; Xu, Y.; Pan, J. 1999: The effects of nitric oxide and endothelia levels on plasma in patients with chronic heart failure Zhonghua Nei Ke Za Zhi 38(5): 306-308
Szepietowski, T.; Abdulla, K. 1988: Isolated ultrafiltration and subsequent dialysis in overhydrated patients with chronic renal failure and hypertension Polski Tygodnik Lekarski 43(15): 471-474
Coves, M.J.; Gomis, R.; Casamitjana, R.; Lienas, V.; Vilaradell, E. 1989: Antihypertensive therapy with guanfacine induces elevated plasma growth hormone levels in diabetic patients Journal of Medicine 20(3-4): 291-296
Holm, J.; Tödt, T.; Berntorp, E.; Erhardt, L. 1998: Failure of thrombolytic therapy in patients with myocardial infarction is associated with high plasma levels of factor VIi antigen Thrombosis and Haemostasis 79(5): 928-931
Jeevanandam, M.; Begay, C.K.; Shahbazian, L.M.; Petersen, S.R. 2000: Altered plasma cytokines and total glutathione levels in parenterally fed critically ill trauma patients with adjuvant recombinant human growth hormone (rhGH) therapy Critical Care Medicine 28(2): 324-329
Rajesh, L.; Karunaianantham, R.; Narayanan, P.R.; Swaminathan, S. 2009: Antiretroviral drug-resistant mutations at baseline and at time of failure of antiretroviral therapy in HIV type 1-coinfected TB patients Aids Research and Human Retroviruses 25(11): 1179-1185
Vorob'ev, N.A.; Nosov, A.K.; Vorob'ev, A.V.; Moiseenko, V.M. 2010: New perspectives in the drug therapy of hormone-resistant prostate cancer Voprosy Onkologii 56(6): 645-653
Ke, Y.N.; Manthey, J. 1987: Hemodynamics associated with the changes in catecholamine, plasma renin activity and antidiuretic hormone in chronic congestive heart failure Zhonghua Nei Ke Za Zhi 26(1): 16-19; 62
Zur Mühlen A von; Hesch, R.D.; Emrich, D.; Creutzfeldt, W. 1971: Effect of synthetic "thyrotropin-releasing factor" on plasma levels of thyrotropin and growth hormone in healthy subjects and patients with hyperthyroidism or primary hypothyroidism German Medical Monthly 1(1): 1-2
Song, J.-p.; Shen, B.; Liu, Z.-h.; Jiang, W.-p. 2003: The changes of plasma levels of brain natriuretic peptides in evaluation of treatment responses in chronic heart failure Zhonghua Nei Ke Za Zhi 42(5): 306-308
Macchi, H.; Fiasse, R.; Reynaert, M.; Desager, J.P.; Dive, C. 1982: Effect of ranitidine (inhibitor of H2 receptors) after I.v. injection to patients treated in an intensive care unit: control of gastric acid secretion and estimation of drug plasma levels Archives Internationales de Pharmacodynamie et de Therapie 256(2): 306-307
Ryckelynck, J.P.; Lobbedez, T.; Valette, B.; Le Goff, C.; Mazouz, O.; Levaltier, B.; Potier, J.C.; Hurault de Ligny, B. 1997: Peritoneal ultrafiltration and refractory congestive heart failure Advances in Peritoneal Dialysis. Conference on Peritoneal Dialysis 13: 93-97
Takahashi, H. 2007: Pathophysiology of heart failure and the biomarkers; brain natriuretic hormone as the class-1 recommendation by the new Japanese Guideline for Heart Failure Rinsho Byori. Japanese Journal of Clinical Pathology 55(12): 1088-1096